Symptoms of convulsions in pregnant women

Update Date: 2021-07-12 Source: Network

summary

Pre convulsion is a common disease for pregnant women, which can lead to death in severe cases. Scientists from the University of reading in the UK recently found a substance related to pre convulsion in pregnant women. Detection of the content of the substance is helpful for early diagnosis and treatment of the disease. I want to talk about the symptoms of convulsions in pregnant women.

Symptoms of convulsions in pregnant women

The incidence rate of convulsion in pregnant women is 10%, usually in the last three months of pregnancy. Symptoms for pregnant women with a sharp rise in blood pressure, swelling of hands and feet, blood clots, severe can lead to convulsion and death. The usual treatment is an immediate C-section, which can lead to premature birth and debilitation.

NKB receptors exist in some organs and tissues related to pre convulsion. For example, there are NKB receptors in the human portal vein, and the function of the portal vein is to transport the digested food to the liver. When the content of NKB in the body is too high, the liver will be greatly affected. The fact shows that the liver is one of the severely damaged organs in pre convulsion cases.

Pre convulsion may be related to the position of the fetus in the mother's uterus. If the location is wrong, it will lead to insufficient blood supply to the fetus, so the placenta will send a large number of chemical signals to the mother, and the blood will be "shunted" from other organs of the pregnant woman to the fetus. This can cause pregnant women in particular parts of the body blood pressure surge, pre convulsion symptoms. Experts believe that NKB may be one of the chemical signals from the placenta.

matters needing attention

Scientists believe that in pregnant women who may have pre convulsion, NKB levels should be high in early pregnancy. By examining the level of NKB in blood, we can find out whether pregnant women are at risk of pre convulsion. At present, some drugs can inhibit the effect of NKB receptor, which is expected to be used to prevent the onset of the disease.